What is NDC 69918-515?

69918-515 is the product NDC for neomycin sulfate, polymyxin b sulfate and dexamethasone, Neomycin sulfate 3.5 mg/mL + 2 more ingredients suspension, listed with the FDA by Nordic Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

neomycin sulfate, polymyxin b sulfate and dexamethasone.

What is the active ingredient?

Neomycin sulfate, Polymyxin b sulfate, Dexamethasone.

Nordic Pharma, Inc., NDC labeler code 69918. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for neomycin sulfate, polymyxin b sulfate and dexamethasone?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

NDC 69918-515

NDC codes

FDA NDC Directory

Product NDC (as listed)69918-515Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69918-0515Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69918-515-05	6991805150569918051505	5 mL in 1 BOTTLE, PLASTIC (69918-515-05)Marketed from Mar 31, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): neomycin sulfate, polymyxin b sulfate and dexamethasone
Generic name (nonproprietary): neomycin sulfate, polymyxin b sulfate and dexamethasone
Active ingredients: Neomycin sulfate — 3.5 mg/mLPolymyxin b sulfate — 10000 [USP'U]/mLDexamethasone — 1 mg/mL
Dosage form: Suspension
Route: Ophthalmic
Labeler: Nordic Pharma, Inc.NDC labeler code 69918
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 050023
Marketing start: Mar 31, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Aminoglycosides (Chemical structure)Corticosteroid Hormone Receptor Agonists (Mechanism)Polymyxins (Chemical structure)
Identifiers: Product ID 69918-515_34028664-7112-42b9-b6fc-5ed048759680SPL ID 34028664-7112-42b9-b6fc-5ed048759680
Pharmacologic class: Aminoglycoside Antibacterial; Corticosteroid; Polymyxin-class Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469918051505 followed by a unit qualifier and the quantity

Package 69918-0515-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 69918-515

What is NDC 69918-515?: 69918-515 is the product NDC for neomycin sulfate, polymyxin b sulfate and dexamethasone, Neomycin sulfate 3.5 mg/mL + 2 more ingredients suspension, listed with the FDA by Nordic Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: neomycin sulfate, polymyxin b sulfate and dexamethasone.
What is the active ingredient?: Neomycin sulfate, Polymyxin b sulfate, Dexamethasone.
Who is the labeler?: Nordic Pharma, Inc., NDC labeler code 69918. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for neomycin sulfate, polymyxin b sulfate and dexamethasone?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 050023

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 050023
Product	Strength	Form · route	Labeler	Product NDC
Maxitrolneomycin sulfate, polymyxin b sulfate and dexamethasone	Neomycin sulfate 3.5 mg/mL + 2 more ingredients	SuspensionOphthalmic	Harrow Eye, LLC	82667-100

neomycin sulfate, polymyxin b sulfate and dexamethasone NDC 69918-515